New hope for advanced cervical cancer patients in clinical trial
Disease control
Not yet recruiting
This study is testing whether new drug combinations work better than standard chemotherapy for advanced cervical cancer that has returned or spread. Researchers will compare LB1410 plus lenvatinib, with or without another drug called LB4330, against chemotherapy chosen by doctors…
Phase: PHASE2, PHASE3 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC